EirGenix provides not just technology services but integral solutions that you can rely on.
Eirgenix develops high quality biologic products, advancing an extensive pipeline of candidates to improve the lives of patients.
EirGenix’s Phase III Clinical Trial of EG12014 Has Enrolled First Patient
2018 Biologics Manufacturing Korea
Cancer Therapeutic Drug EG12014 Is Approved For Phase III Clinical Trial
EirGenix Is Award Top 145 Of The Technology Fast 500 Companies In Asia Pacific (APAC)
Our facility is located in Taiwan, and offers the service to clients around the world.
